Holen Sie sich die Stockscreener-App
104.65
2.81%
2.86
Schlusskurs vom Vortag:
$101.79
Offen:
$101.79
24-Stunden-Volumen:
626.32K
Relative Volume:
1.21
Marktkapitalisierung:
$3.44B
Einnahmen:
$787.85M
Nettoeinkommen (Verlust:
$-27.78M
KGV:
-120.62
EPS:
-0.8676
Netto-Cashflow:
$18.75M
1W Leistung:
-7.12%
1M Leistung:
-5.67%
6M Leistung:
-37.89%
1J Leistung:
-28.09%
1-Tages-Spanne:
$100.85
$105.05
1-Wochen-Bereich:
$100.85
$115.32
52-Wochen-Spanne:
$100.85
$212.00
Irhythm Holdings Inc Stock (IRTC) Company Profile
Firmenname
Irhythm Holdings Inc
Sektor
Branche
Telefon
415-632-5700
Adresse
699 8TH STREET, San Francisco, CA
Compare IRTC vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IRTC
Irhythm Holdings Inc
|
104.65 | 3.44B | 787.85M | -27.78M | 18.75M | -0.8676 |
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Irhythm Holdings Inc Stock (IRTC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2025-09-23 | Eingeleitet | Evercore ISI | In-line |
| 2025-08-20 | Eingeleitet | BofA Securities | Buy |
| 2025-05-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-12-03 | Fortgesetzt | Wells Fargo | Equal Weight |
| 2024-10-04 | Eingeleitet | Goldman | Neutral |
| 2024-06-20 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-12-11 | Hochstufung | Citigroup | Neutral → Buy |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2023-02-07 | Eingeleitet | Wells Fargo | Overweight |
| 2022-11-07 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2022-06-09 | Herabstufung | Citigroup | Buy → Neutral |
| 2022-04-06 | Eingeleitet | Wolfe Research | Underperform |
| 2022-02-24 | Hochstufung | Needham | Hold → Buy |
| 2022-01-18 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2022-01-12 | Hochstufung | BTIG Research | Neutral → Buy |
| 2022-01-11 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2021-12-21 | Fortgesetzt | Canaccord Genuity | Buy |
| 2021-12-17 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-12-15 | Hochstufung | Citigroup | Neutral → Buy |
| 2021-06-02 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-04-13 | Herabstufung | BTIG Research | Buy → Neutral |
| 2021-04-12 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2021-02-26 | Herabstufung | Colliers Securities | Buy → Neutral |
| 2021-01-29 | Bestätigt | Needham | Hold |
| 2020-11-17 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2020-09-11 | Eingeleitet | Needham | Hold |
| 2020-09-02 | Eingeleitet | Robert W. Baird | Neutral |
| 2020-08-07 | Hochstufung | Colliers Securities | Neutral → Buy |
| 2020-08-05 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2020-03-05 | Eingeleitet | Citigroup | Buy |
| 2020-02-06 | Eingeleitet | BTIG Research | Buy |
| 2020-01-10 | Eingeleitet | William Blair | Outperform |
| 2020-01-08 | Eingeleitet | SunTrust | Buy |
| 2019-10-22 | Eingeleitet | Oppenheimer | Perform |
| 2019-02-20 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2018-09-13 | Bestätigt | Canaccord Genuity | Buy |
| 2018-09-06 | Eingeleitet | Chardan Capital Markets | Buy |
| 2018-08-02 | Hochstufung | Dougherty & Company | Sell → Neutral |
| 2018-07-16 | Herabstufung | Dougherty & Company | Neutral → Sell |
| 2017-12-01 | Eingeleitet | Dougherty & Company | Neutral |
Alle ansehen
Irhythm Holdings Inc Aktie (IRTC) Neueste Nachrichten
Top 3 Health Care Stocks You'll Regret Missing In Q2 - Benzinga
iRhythm Technologies Inc (IRTC) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hackers demand payment for stolen data tied to heart monitoring company iRhythm - The Business Journals
iRhythm Technologies Inc (IRTC) Institutional Confidence - TradingKey
iRhythm Hit by Cyberattack, Patient Data Stolen and Ransom Demanded - Security Affairs
iRhythm Investigates Cyber Incident After Hackers Claim Access To Sensitive DataiRhythm Holdings (NASD - Benzinga
iRhythm discloses cybersecurity incident (IRTC:NASDAQ) - Seeking Alpha
iRhythm Holdings, Inc. 8-K SEC Filing June 2026 – Company Details, Address, and Stock Information - Minichart
iRhythm discloses cyber incident, says no impact on device systems, patient safety - Reuters
Cyberattack at iRhythm (NASDAQ: IRTC) involves PHI but no system outage - Stock Titan
iRhythm Holdings (IRTC) Hovers Near Resistance as Consolidation ContinuesGamma Squeeze - newsline.com
IRTC Q1 2026 Earnings: EPS Surprise of 47.13% Beats ExpectationsROA Comparison - newsline.com
iRhythm Holdings (IRTC) Grinds Higher as Stock Holds Above Key Support LevelCalendar Spread Trade - newsline.com
IRTC Q1 2026 Earnings: Strong EPS Beat Amidst Absent Revenue DisclosureMargin Expansion Trends - newsline.com
Why iRhythm Holdings, Inc. (IRTC) is a top momentum stock for the long term - MSN
iRhythm Holdings (IRTC) Slides 1.08% as Support Levels Come into FocusStock Picks - newsline.com
IRTC Reiterated by BTIG -- Price Target Maintained at $185 - GuruFocus
Q1 2026 iRhythm Holdings, Inc Earnings Call Transcript - GuruFocus
iRhythm Holdings, Inc at Bank of America Global Healthcare Conference Transcript - GuruFocus
How iRhythm’s Governance Overhaul and Shelf Registration Could Reshape the Risk Profile for IRTC Investors - simplywall.st
iRhythm Holdings, Inc. (IRTC) Stock Analysis: Navigating a 65% Potential Upside in the Medical Devices Sector - DirectorsTalk Interviews
iRhythm Holdings (IRTC) Edges Higher as Stock Tests Key Resistance ZoneEqual Weight ETF - newsline.com
IRTC Q1 2026 Earnings: EPS Beats Estimates by Wide Margin but Revenue Not ReportedEarnings Weakness Phase - newsline.com
A Look At iRhythm Holdings (IRTC) Valuation After Governance Changes And Litigation Settlement - Yahoo Finance
IRTC Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Mild Stock UptickRevenue Surprise History - newsline.com
iRhythm Holdings (IRTC) Posts Modest Gain, Maintains Support Above $102.7AD Line Divergence - newsline.com
iRhythm Holdings, Inc. Files Form 8-K with SEC – Company Details, Stock Symbol IRTC, and NASDAQ Listing Information - Minichart
iRhythm Holdings (IRTC) was Trimmed Following Strong Performance - Insider Monkey
iRhythm reaches $45M settlement to resolve securities class action - TradingView
iRhythm Holdings (NASDAQ: IRTC) agrees to $45M securities class action settlement - Stock Titan
iRhythm (NASDAQ: IRTC) EVP sells 1,716 shares to cover RSU taxes - Stock Titan
iRhythm (NASDAQ: IRTC) CAO acquires ESPP shares, sells some for taxes - Stock Titan
iRhythm Holders Back Governance Shift As Shares Trade Below Estimates - Sahm
IRTC: FDA-cleared algorithm, strong Q1 growth, and primary care expansion drive raised outlook - TradingView
IRTC Maintained by Canaccord Genuity -- Price Target Lowered to $152 - GuruFocus
iRhythm (IRTC) chief commercial & product officer acquires 177 ESPP shares - Stock Titan
iRhythm Holdings (IRTC) executive adds 137 ESPP shares, holds 55,043 - Stock Titan
iRhythm (IRTC) EVP adds shares through 2016 Employee Stock Purchase Plan - Stock Titan
iRhythm (IRTC) CEO Blackford adds 178 shares via 2016 ESPP plan - Stock Titan
2 Reasons to Like IRTC and 1 to Stay Skeptical - Yahoo Finance
IRhythm Holdings, Inc. (IRTC) Stock Analysis: Riding The Wave Of A 57% Potential Upside - DirectorsTalk Interviews
iRhythm Holdings Inc. (IRTC) Q1 2026 Earnings: EPS Beat Signals Cost Discipline Amid Strategic ShiftsUpward Estimate Revision - The Legal Advocate
iRhythm Holdings (IRTC) director granted 1,573 RSUs in equity award - Stock Titan
Director Bruce Bodaken of iRhythm (NASDAQ: IRTC) receives 1,573 RSUs in equity grant - Stock Titan
Director at iRhythm (IRTC) receives 1,573 RSU equity award, now holds 11,141 shares - Stock Titan
Director at iRhythm (IRTC) granted 1,573 restricted stock units in equity award - Stock Titan
Director at iRhythm (NASDAQ: IRTC) receives 1,573 RSU award - Stock Titan
Director at iRhythm Holdings (IRTC) receives 1,573 restricted stock units - Stock Titan
Director at iRhythm (IRTC) awarded 1,573 restricted stock units in Form 4 - Stock Titan
iRhythm Holdings, Inc. Files Form 8-K Reporting Annual Shareholder Meeting Results and Company Details (May 27, 2026) - Minichart
iRhythm (IRTC) shareholders approve 2026 equity plan, directors and auditor - Stock Titan
Finanzdaten der Irhythm Holdings Inc-Aktie (IRTC)
Umsatz
Nettogewinn
Free Cashflow
ENV
Irhythm Holdings Inc-Aktie (IRTC) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Rosenbaum Marc Wade | Chief Accounting Officer |
Jun 02 '26 |
Sale |
108.19 |
729 |
78,870 |
16,155 |
| TALWALKAR ABHIJIT Y | Director |
May 11 '26 |
Buy |
10.71 |
5,312 |
56,892 |
25,611 |
| TALWALKAR ABHIJIT Y | Director |
May 11 '26 |
Sale |
117.93 |
5,312 |
626,430 |
20,299 |
0.93%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):